Cancer-related fatigue
Conditions
Interventions
Control Group:Conventional symptomatic treatment with integrated Traditional Chinese and Western medicine
Observation of Group A:Moxibustion + symptomatic supportive therapy
Observation of Group B:Adopting Traditional Chinese Medicine invigorating qi and warming yang Tincture+Thunder Fire Moxibustion+Symptomatic supportive treatment
Sponsors
Shenzhen Hospital (Longgang), Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) Meets the diagnostic criteria for the subjects in both traditional Chinese medicine (TCM) and Western medicine 2) Karnofsky Performance Status (KPS) = 60 points 3) Aged between 18 and 80 years old 4) Has clear consciousness, fully understands the content of the study, and voluntarily agrees to participate in this research 5) Has basically normal immune function, bone marrow reserve, and heart, liver, and kidney functions, with no history of primary endocrine diseases 6) Has an expected survival period of at least 3 months 7) Has good compliance, can maintain an independent position, and has good follow-up
Exclusion criteria
Exclusion criteria: 1) Patients with severe primary diseases of the cardiovascular, cerebrovascular, hematopoietic, autoimmune, or neuropsychiatric systems 2) Patients with local skin ulceration, infection, high fever, or severe systemic infections, or those with uncontrollable organic diseases 3) Pregnant or breastfeeding women, those planning pregnancy in the near future, or patients with (functional uterine bleeding) 4) Patients with severe allergies, those with allergies to the adjuvants or components of traditional Chinese medicine tincture for external use, or those allergic to the drugs in (a type of moxibustion), or those who experience (fainting during moxibustion) 5) Patients with active bleeding or severe coagulation disorders (e.g., glaucoma, retinal hemorrhage, or ocular bleeding due to trauma) 6) Patients currently using immunosuppressive drugs or those who have undergone organ transplantation and are on long-term immunosuppressive therapy 7) Patients with severe liver or kidney dysfunction (serum creatinine =1.5×ULN; ALT or AST =5×ULN; bilirubin =1.5×ULN) or those currently taking cephalosporin antibiotics (potential interaction with tinctures)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Piper Fatigue Scale Score;Quality of Life Assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Performance Status Score;The quality of life scores for cancer patients;Traditional Chinese Medicine Syndrome Integral Evaluation; | — |
Countries
China
Contacts
Public ContactLIU PENG
Shenzhen Hospital (Longgang), Beijing University of Chinese Medicine
Outcome results
None listed